Loading…

Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports

A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVI...

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine 2022/06/15, Vol.61(12), pp.1869-1876
Main Authors: Oka, Hideaki, Homma, Yoshito, Nishino, Yuki, Suemori, Koichiro, Sato, Norio, Sakurai, Yuko, Sekimoto, Mizuki, Ando, Shota, Iwamoto, Saki, Iwamoto, Takaki, Kondo, Mika, Kamimura, Taro, Nakano, Toshiaki, Kitazono, Takanari
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19.
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.8976-21